These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 18224381
1. Categorization of non-mass-like breast lesions detected by MRI. Sakamoto N, Tozaki M, Higa K, Tsunoda Y, Ogawa T, Abe S, Ozaki S, Sakamoto M, Tsuruhara T, Kawano N, Suzuki T, Yamashiro N, Fukuma E. Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381 [Abstract] [Full Text] [Related]
2. MR-guided vacuum-assisted breast biopsy: is it an essential technique? Tozaki M, Yamashiro N, Suzuki T, Kawano N, Ozaki S, Sakamoto N, Abe S, Ogawa T, Katayama N, Tsunoda Y, Fukuma E. Breast Cancer; 2009; 16(2):121-5. PubMed ID: 18807122 [Abstract] [Full Text] [Related]
3. MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Gökalp G, Topal U. Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732 [Abstract] [Full Text] [Related]
4. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement. Tozaki M, Igarashi T, Fukuda K. AJR Am J Roentgenol; 2006 Aug; 187(2):313-21. PubMed ID: 16861532 [Abstract] [Full Text] [Related]
5. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population? Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E. Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125 [Abstract] [Full Text] [Related]
10. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI]. Siegmann KC, Moron HU, Baur A, Hahn M, Vogel U, Claussen CD, Bitzer M. Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398 [Abstract] [Full Text] [Related]
11. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy. Uematsu T, Kasami M. AJR Am J Roentgenol; 2012 May; 198(5):1223-30. PubMed ID: 22528918 [Abstract] [Full Text] [Related]
12. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. Yabuuchi H, Matsuo Y, Kamitani T, Setoguchi T, Okafuji T, Soeda H, Sakai S, Hatakenaka M, Kubo M, Tokunaga E, Yamamoto H, Honda H. Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900 [Abstract] [Full Text] [Related]
13. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD. Breast J; 2007 Jul; 13(6):545-50. PubMed ID: 17983393 [Abstract] [Full Text] [Related]
14. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination. Sadowski EA, Kelcz F. J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907 [Abstract] [Full Text] [Related]
16. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet. Meeuwis C, Peters NH, Mali WP, Gallardo AM, van Hillegersberg R, Schipper ME, van den Bosch MA. Eur J Radiol; 2007 May; 62(2):283-8. PubMed ID: 17218074 [Abstract] [Full Text] [Related]
18. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement. van de Ven SM, Lin MC, Daniel BL, Sareen P, Lipson JA, Pal S, Dirbas FM, Ikeda DM. J Magn Reson Imaging; 2010 Jul; 32(1):101-9. PubMed ID: 20575077 [Abstract] [Full Text] [Related]
19. Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Facius M, Renz DM, Neubauer H, Böttcher J, Gajda M, Camara O, Kaiser WA. Clin Imaging; 2007 Jul; 31(6):394-400. PubMed ID: 17996602 [Abstract] [Full Text] [Related]